• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

可能患有曲霉菌感染的重症流感患者的死亡率高于那些同时患有和不患有其他合并感染的患者。

Higher mortality of severe influenza patients with probable aspergillosis than those with and without other coinfections.

机构信息

Division of Infectious Diseases, Department of Internal Medicine, Chi Mei Medical Center-Liouying, Tainan City, Taiwan.

Department of Intensive Care Medicine, Chi-Mei Medical Center, Tainan, Taiwan.

出版信息

J Formos Med Assoc. 2017 Sep;116(9):660-670. doi: 10.1016/j.jfma.2017.06.002. Epub 2017 Jun 21.

DOI:10.1016/j.jfma.2017.06.002
PMID:28647219
Abstract

BACKGROUND/PURPOSE: Aspergillus-associated infection might comprise up to 23-29% of severe influenza patients from the community throughout stay in an intensive care unit (ICU). In Taiwan, cases of severe influenza with aspergillosis are increasingly reported. Therefore, we describe the relative risk of mortality among severe influenza patients with aspergillosis and other coinfections compared to severe influenza patients without Aspergillus coinfections.

METHODS

We retrospectively reviewed 124 adult patients with severe influenza in a tertiary medical center in southern Taiwan from January 2015 through March 2016. The definition of probable aspergillosis required abnormal radiological findings and positive Aspergillus galactomannan (GM) antigen and/or Aspergillus isolation.

RESULTS

Probable aspergillosis (detected throughout the whole course) and other coinfections (only community-acquired) were diagnosed in 21 (17%) and 38 (31%) of all patients respectively. Klebsiella pneumoniae (36.8%), Pseudomonas aeruginosa (31.6%) and Staphylococcus aureus (31.6%) were the most frequent isolates of other coinfections. In-ICU mortality of Aspergillus group (66.7%) was significantly higher than other coinfections (23.7%, p = 0.001) or control group without coinfections (15.4%, p < 0.001), with significant odds ratios after adjusting for important variables. The factor of GM index ≥0.6 had a 19.82 (95% CI, 4.91 to 80.07, p < 0.0001) odds of expiring in an ICU among the Aspergillus group.

CONCLUSION

Dual Aspergillus and influenza infection is emerging in southern Taiwan. Meanwhile, community-acquired P. aeruginosa should be listed in the common copathogens with severe influenza. The 67% mortality linked to aspergillosis highlights the need for physicians to focus attention on patients with GM ≥ 0.6.

摘要

背景/目的:曲霉菌相关感染可能占社区重症流感患者入住重症监护病房(ICU)期间的 23-29%。在台湾,越来越多的严重流感伴曲霉菌病的病例被报道。因此,我们描述了与无曲霉菌合并感染的严重流感患者相比,合并曲霉菌感染和其他合并感染的严重流感患者的死亡率的相对风险。

方法

我们回顾性分析了 2015 年 1 月至 2016 年 3 月在台湾南部一家三级医疗中心的 124 例成年严重流感患者。疑似曲霉菌病的定义需要异常的影像学发现和阳性的曲霉菌半乳甘露聚糖(GM)抗原和/或曲霉菌分离。

结果

在所有患者中,分别有 21 例(17%)和 38 例(31%)被诊断为疑似曲霉菌病(整个病程中均存在)和其他合并感染(仅为社区获得性)。最常见的其他合并感染分离株是肺炎克雷伯菌(36.8%)、铜绿假单胞菌(31.6%)和金黄色葡萄球菌(31.6%)。曲霉菌组的 ICU 死亡率(66.7%)明显高于其他合并感染组(23.7%,p=0.001)或无合并感染组(15.4%,p<0.001),在调整了重要变量后,差异具有统计学意义。GM 指数≥0.6 的因素使曲霉菌组 ICU 死亡率增加了 19.82 倍(95%可信区间,4.91 至 80.07,p<0.0001)。

结论

曲霉菌和流感的双重感染在台湾南部逐渐出现。同时,社区获得性铜绿假单胞菌应被列入与严重流感常见的共病原体。与曲霉菌病相关的 67%的死亡率强调了医生需要关注 GM 值≥0.6 的患者。

相似文献

1
Higher mortality of severe influenza patients with probable aspergillosis than those with and without other coinfections.可能患有曲霉菌感染的重症流感患者的死亡率高于那些同时患有和不患有其他合并感染的患者。
J Formos Med Assoc. 2017 Sep;116(9):660-670. doi: 10.1016/j.jfma.2017.06.002. Epub 2017 Jun 21.
2
Coinfection and superinfection in ICU critically ill patients with severe COVID-19 pneumonia and influenza pneumonia: are the pictures different?COVID-19 重症肺炎和流感肺炎 ICU 危重症患者的合并感染和再感染:两者的表现是否不同?
Front Public Health. 2023 Aug 29;11:1195048. doi: 10.3389/fpubh.2023.1195048. eCollection 2023.
3
Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study.重症监护病房中因严重流感入院的患者侵袭性曲霉菌病:一项回顾性队列研究。
Lancet Respir Med. 2018 Oct;6(10):782-792. doi: 10.1016/S2213-2600(18)30274-1. Epub 2018 Jul 31.
4
High-level ambient particulate matter before influenza attack with increased incidence of Aspergillus antigenemia in Southern Taiwan, 2016.2016 年台湾南部流感发病前高水平环境细颗粒物与曲霉菌抗原血症发生率增加。
J Microbiol Immunol Infect. 2018 Feb;51(1):141-147. doi: 10.1016/j.jmii.2016.09.001. Epub 2016 Dec 18.
5
Factors associated with coinfections in invasive aspergillosis: a retrospective cohort study.与侵袭性曲霉病合并感染相关的因素:一项回顾性队列研究。
Clin Microbiol Infect. 2021 Nov;27(11):1644-1651. doi: 10.1016/j.cmi.2021.02.021. Epub 2021 Mar 2.
6
A Pathology-based Case Series of Influenza- and COVID-19-associated Pulmonary Aspergillosis: The Proof Is in the Tissue.基于病理学的流感和 COVID-19 相关肺曲霉病病例系列:证据就在组织中。
Am J Respir Crit Care Med. 2023 Aug 1;208(3):301-311. doi: 10.1164/rccm.202208-1570OC.
7
Coinfection with Staphylococcus aureus increases risk of severe coagulopathy in critically ill children with influenza A (H1N1) virus infection.金黄色葡萄球菌合并感染增加危重症甲型 H1N1 流感患儿发生严重凝血功能障碍的风险。
Crit Care Med. 2012 Dec;40(12):3246-50. doi: 10.1097/CCM.0b013e318260c7f8.
8
Aspergillus coinfection in critically Ill patients with severe dengue.重症登革热患者合并曲霉属感染。
J Infect Public Health. 2023 Dec;16(12):1893-1897. doi: 10.1016/j.jiph.2023.09.008. Epub 2023 Sep 22.
9
Clinical characteristics, bacterial coinfections and outcomes in COVID-19-associated pulmonary aspergillosis in a third-level Mexican hospital during the COVID-19 pre-vaccination era.COVID-19 疫苗接种前时代三级墨西哥医院 COVID-19 相关肺曲霉病的临床特征、细菌合并感染和结局。
Mycoses. 2024 Jan;67(1):e13693. doi: 10.1111/myc.13693.
10
Influenza-associated invasive aspergillosis in patients admitted to the intensive care unit in Sweden: a prospective multicentre cohort study.瑞典重症监护病房患者中与流感相关的侵袭性曲霉病:一项前瞻性多中心队列研究
Infect Dis (Lond). 2024 Feb;56(2):110-115. doi: 10.1080/23744235.2023.2273381. Epub 2023 Dec 18.

引用本文的文献

1
Key fungal coinfections: epidemiology, mechanisms of pathogenesis, and beyond.关键真菌合并感染:流行病学、发病机制及其他
mBio. 2025 May 14;16(5):e0056225. doi: 10.1128/mbio.00562-25. Epub 2025 Apr 2.
2
identification through bronchoscope in intensive care unit - a retrospective, databased cohort study.重症监护病房中通过支气管镜进行的识别——一项基于数据库的回顾性队列研究
Front Cell Infect Microbiol. 2025 Jan 13;14:1471298. doi: 10.3389/fcimb.2024.1471298. eCollection 2024.
3
Invasive pulmonary aspergillosis among patients with severe community-acquired pneumonia and influenza in ICUs: a retrospective cohort study.
重症监护病房中重症社区获得性肺炎和流感患者的侵袭性肺曲霉病:一项回顾性队列研究。
Pneumonia (Nathan). 2024 May 25;16(1):10. doi: 10.1186/s41479-024-00129-9.
4
Clinical characteristics and assessment of risk factors in patients with influenza A-induced severe pneumonia after the prevalence of SARS-CoV-2.SARS-CoV-2流行后甲型流感所致重症肺炎患者的临床特征及危险因素评估
Open Med (Wars). 2024 Apr 15;19(1):20240953. doi: 10.1515/med-2024-0953. eCollection 2024.
5
Use of nebulized liposomal amphotericin B and posaconazole as antifungal prophylaxis in patients with severe SARS-CoV2 infection in intensive care unit.在重症监护病房中,使用雾化脂质体两性霉素 B 和泊沙康唑作为严重 SARS-CoV2 感染患者的抗真菌预防药物。
Infection. 2024 Aug;52(4):1459-1468. doi: 10.1007/s15010-024-02234-9. Epub 2024 Mar 26.
6
Missed Opportunities for Antifungal Stewardship during the COVID-19 Era.COVID-19 大流行期间抗真菌药物管理的错失机遇
Antibiotics (Basel). 2023 Aug 23;12(9):1352. doi: 10.3390/antibiotics12091352.
7
Early Detection of Aspergillus Species in Lower Respiratory Tract is Associated with Higher Mortality in Viral Community-Acquired Pneumonia: A Multicenter Prospective Cohort Study in China.在中国的一项多中心前瞻性队列研究中,下呼吸道曲霉属物种的早期检测与病毒性社区获得性肺炎的死亡率升高相关。
Lung. 2023 Aug;201(4):387-396. doi: 10.1007/s00408-023-00638-2. Epub 2023 Jul 22.
8
Invasive Pulmonary Aspergillosis in Coronavirus Disease 2019 Patients Lights and Shadows in the Current Landscape.COVID-19 相关侵袭性肺曲霉病:当前形势下的喜与忧。
Adv Respir Med. 2023 May 8;91(3):185-202. doi: 10.3390/arm91030016.
9
Analysis of risk factors of fungal superinfections in viral pneumonia patients: A systematic review and meta-analysis.病毒性肺炎患者真菌感染的危险因素分析:系统评价和荟萃分析。
Immun Inflamm Dis. 2023 Jan;11(1):e760. doi: 10.1002/iid3.760.
10
Could the Lung Be a Gateway for Amphotericin B to Attack the Army of Fungi?肺会是两性霉素B对抗真菌大军的门户吗?
Pharmaceutics. 2022 Dec 3;14(12):2707. doi: 10.3390/pharmaceutics14122707.